David L. Groteluschen

Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study

Anne M. Traynor, Sarita Dubey, Jens C. Eickhoff et al. · Journal of Thoracic Oncology · 2009 · 139 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy

Jeanette A. Lawrence, Leah Griffin, Ernie Balcueva et al. · Journal of Cancer Survivorship · 2015 · 95 citations · Full text

Medicine, Oncology, Psychiatry +16

A Phase 2 Trial of Flavopiridol (Alvocidib) and Cisplatin in Platin-Resistant Ovarian and Primary Peritoneal Carcinoma: MC0261

Keith C. Bible, Prema P. Peethambaram, Ann L. Oberg et al. · Gynecologic Oncology · 2012 · 58 citations

Medicine, Oncology, Pharmacology +14

Capecitabine-Related Neurotoxicity Presenting as Trismus

Linda S.B. Couch, David L. Groteluschen, James A. Stewart et al. · Clinical Colorectal Cancer · 2003 · 31 citations

Pharmacy, Neurology, Neurologic Pharmacotherapy +8

A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study

Noelle K. LoConte, Kyle D. Holen, William R. Schelman et al. · Investigational New Drugs · 2012 · 11 citations · Full text

Medicine, Oncology, Pharmacology +13